This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Episode 2

“The Burden of Clostridioides difficile Infection In the COVID-19 Era” Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics Evidence-Based Hand Hygiene In the Post-COVID World.” Tamas Haidegger (Speaker) Associate Professor, Óbuda University ** We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.